Taraneh Givi
YOU?
Author Swipe
View article: Nano-curcumin enhances the sensitivity of tamoxifen-resistant breast cancer cells via the Cyclin D1-DILA1 axis and the PI3K/AKT/mTOR pathway downregulation
Nano-curcumin enhances the sensitivity of tamoxifen-resistant breast cancer cells via the Cyclin D1-DILA1 axis and the PI3K/AKT/mTOR pathway downregulation Open
This research investigates the effects of nano-curcumin on the expression of Cyclin D1 and DILA1 genes, as well as on the PI3K/AKT/mTOR pathway, in tamoxifen-sensitive and resistant MCF-7 breast cancer cell lines. The IC50 values were dete…
View article: <scp><i>LINC01116</i></scp> affects patient survival differently and is dissimilarly expressed in <scp>ER</scp>+ and <scp>ER</scp>− breast cancer samples
<span><i>LINC01116</i></span> affects patient survival differently and is dissimilarly expressed in <span>ER</span>+ and <span>ER</span>− breast cancer samples Open
Background Breast cancer is the most commonly detected cancer and one of the leading causes of cancer mortality. Emerging evidence supports that aberrant expression of lncRNAs is correlated with tumor progression and various aspects of tum…